These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34297364)

  • 1. Facioscapulohumeral muscular dystrophy-Reproductive counseling, pregnancy, and delivery in a complex multigenetic disease.
    Vincenten SCC; Van Der Stoep N; Paulussen ADC; Mul K; Badrising UA; Kriek M; Van Der Heijden OWH; Van Engelen BGM; Voermans NC; De Die-Smulders CEM; Lassche S
    Clin Genet; 2022 Feb; 101(2):149-160. PubMed ID: 34297364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facioscapulohumeral Muscular Dystrophy.
    Statland JM; Tawil R
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1916-1931. PubMed ID: 27922500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and molecular diagnosis of facioscapulohumeral dystrophy type 1 (FSHD1) in 2012].
    Salort-Campana E; Nguyen K; Lévy N; Pouget J; Attarian S
    Rev Neurol (Paris); 2013; 169(8-9):573-82. PubMed ID: 24011979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Facioscapulohumeral muscular dystrophy type 2].
    Sacconi S; Desnuelle C
    Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: Update of the 2012 guidelines.
    Giardina E; Camaño P; Burton-Jones S; Ravenscroft G; Henning F; Magdinier F; van der Stoep N; van der Vliet PJ; Bernard R; Tomaselli PJ; Davis MR; Nishino I; Oflazer P; Race V; Vishnu VY; Williams V; Sobreira CFR; van der Maarel SM; Moore SA; Voermans NC; Lemmers RJLF
    Clin Genet; 2024 Jul; 106(1):13-26. PubMed ID: 38685133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.
    Mul K; Voermans NC; Lemmers RJLF; Jonker MA; van der Vliet PJ; Padberg GW; van Engelen BGM; van der Maarel SM; Horlings CGC
    Clin Genet; 2018 Dec; 94(6):521-527. PubMed ID: 30211448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.
    Attarian S; Salort-Campana E; Nguyen K; Behin A; Andoni Urtizberea J
    Rev Neurol (Paris); 2012 Dec; 168(12):910-8. PubMed ID: 22551571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 FSHD with 6-10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention.
    Salort-Campana E; Fatehi F; Beloribi-Djefaflia S; Roche S; Nguyen K; Bernard R; Cintas P; Solé G; Bouhour F; Ollagnon E; Sacconi S; Echaniz-Laguna A; Kuntzer T; Levy N; Magdinier F; Attarian S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic counseling and testing for FSHD (facioscapulohumeral muscular dystrophy) in the Israeli population.
    Yanoov-Sharav M; Leshinsky-Silver E; Cohen S; Vinkler C; Michelson M; Lerman-Sagie T; Ginzberg M; Sadeh M; Lev D
    J Genet Couns; 2012 Aug; 21(4):557-63. PubMed ID: 22109111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings.
    Jia FF; Drew AP; Nicholson GA; Corbett A; Kumar KR
    Neuromuscul Disord; 2021 Nov; 31(11):1101-1112. PubMed ID: 34711481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].
    Jordan B; Müller-Reible C; Zierz S
    Nervenarzt; 2011 Jun; 82(6):712-22. PubMed ID: 21567298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic analysis of Korean patients with facioscapulohumeral muscular dystrophy.
    Ki CS; Lee ST; Kim KS; Kim JW; Hong YH; Sung JJ; Park KS; Lee KW
    J Korean Med Sci; 2008 Dec; 23(6):959-63. PubMed ID: 19119436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1.
    Larsen M; Rost S; El Hajj N; Ferbert A; Deschauer M; Walter MC; Schoser B; Tacik P; Kress W; Müller CR
    Eur J Hum Genet; 2015 Jun; 23(6):808-16. PubMed ID: 25370034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era.
    Zampatti S; Colantoni L; Strafella C; Galota RM; Caputo V; Campoli G; Pagliaroli G; Carboni S; Mela J; Peconi C; Gambardella S; Cascella R; Giardina E
    Neurogenetics; 2019 May; 20(2):57-64. PubMed ID: 30911870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers.
    Gaillard MC; Roche S; Dion C; Tasmadjian A; Bouget G; Salort-Campana E; Vovan C; Chaix C; Broucqsault N; Morere J; Puppo F; Bartoli M; Levy N; Bernard R; Attarian S; Nguyen K; Magdinier F
    Neurology; 2014 Aug; 83(8):733-42. PubMed ID: 25031281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.
    Rieken A; Bossler AD; Mathews KD; Moore SA
    Neurology; 2021 Feb; 96(7):e1054-e1062. PubMed ID: 33443126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies.
    Nikolic A; Jones TI; Govi M; Mele F; Maranda L; Sera F; Ricci G; Ruggiero L; Vercelli L; Portaro S; Villa L; Fiorillo C; Maggi L; Santoro L; Antonini G; Filosto M; Moggio M; Angelini C; Pegoraro E; Berardinelli A; Maioli MA; D'Angelo G; Di Muzio A; Siciliano G; Tomelleri G; D'Esposito M; Della Ragione F; Brancaccio A; Piras R; Rodolico C; Mongini T; Magdinier F; Salsi V; Jones PL; Tupler R
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.